Overview Request Sample Pages Request Customization Download PDF
You are viewing: Germany Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The Germany Gastrointestinal Stent Market was valued at $38.79 Million in 2026 and projected to reach to $53.48 Million by 2031, representing a compound annual growth rate of 6.6%. Germany's gastrointestinal stent market is positioned for steady growth through 2031, driven by an aging population with increasing prevalence of gastrointestinal disorders and rising demand for minimally invasive treatment options.

Germany Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Germany Gastrointestinal Stent Market Trends and Insights

  • Germany's advanced healthcare infrastructure and high adoption of minimally invasive procedures are driving demand for gastrointestinal stents across the country.
  • The market in Germany is supported by strong reimbursement policies, an aging population, and increasing prevalence of gastrointestinal disorders requiring endoscopic intervention. The forecast period from 2026 to 2031 reflects Germany's commitment to innovative medical device adoption and improved patient outcomes through stent-based therapies.
  • Germany's position as a leading European healthcare market ensures continued investment in gastrointestinal stent technologies and clinical applications.
  • Market growth in Germany is underpinned by rising healthcare expenditure, expanding hospital networks, and growing awareness among physicians and patients regarding the benefits of stent placement for biliary, esophageal, and colorectal conditions..

Key Market Statistics

  • CAGR (2026-2031) 6.6% CAGR
  • Market Size, 2026 ~USD 38.79 Million
  • Forecast, 2031 ~USD 53.48 Million
  • Country Germany

Germany Gastrointestinal Stent Market Overview

Market Size & Growth :

Germany's gastrointestinal stent market is valued at $38.79 million in 2026 and is projected to reach $53.48 million by 2031, with a robust CAGR of 6.6%, outpacing the global average of 5.7%.

Advanced Healthcare Infrastructure :

Germany's world-class healthcare system and high penetration of minimally invasive surgical techniques drive strong adoption of gastrointestinal stents across hospitals and specialized clinics nationwide.

Reimbursement Support :

Strong reimbursement policies from German statutory health insurance (Krankenkassen) and private insurers provide favorable coverage for gastrointestinal stent procedures, reducing patient out-of-pocket costs.

Clinical Excellence :

Germany's leading gastroenterology centers and interventional radiology departments maintain high procedural volumes, supporting market expansion and driving innovation in stent technology adoption.

Germany Gastrointestinal Stent Market Dynamics

  • The country's robust healthcare infrastructure, coupled with strong reimbursement mechanisms, creates a favorable environment for market expansion.
  • Healthcare providers are increasingly adopting advanced stent technologies to improve patient outcomes and reduce hospital stays. Key growth drivers include rising incidence of esophageal and biliary strictures, growing preference for endoscopic interventions over surgical alternatives, and continuous product innovation by leading manufacturers.
  • Germany's emphasis on cost-effective healthcare solutions and evidence-based medicine further supports market penetration.
  • Strategic partnerships between hospitals and medical device companies are expected to accelerate market development through 2031..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Germany's gastrointestinal stent market will grow from $38.79M (2026) to $53.48M (2031) at a 6.6% CAGR.
    • Germany's advanced healthcare system and strong reimbursement framework support high adoption of minimally invasive stent procedures.
    • An aging population and rising prevalence of gastrointestinal disorders are key growth drivers in Germany.
    • Germany's position as a leading European medical device market ensures continued innovation and investment in stent technologies.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    Germany Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    GERMANY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS2.82.93.13.43.63.94.14.47.2
    HOSPITALS & CLINICS23.925.426.928.630.432.334.436.66.4
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS7.68.28.79.31010.711.512.47.3
    TOTAL34.336.538.841.34446.950.153.56.6

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Germany-specific market data to assess market opportunity, develop localized product strategies, and identify distribution partnerships within Europe's largest healthcare market.
    • Healthcare Investors & PE Firms : Investors require detailed German market analysis to evaluate investment opportunities in gastrointestinal stent companies, assess growth potential, and benchmark against global market trends.
    • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to inform procurement decisions, budget planning, and technology adoption strategies for gastrointestinal stent programs.
    • Market Consultants & Analysts : Consultants require Germany-specific data to support client advisory work, competitive analysis, and strategic recommendations for healthcare and medical device sector clients.
    • Regulatory & Compliance Officers : Compliance professionals need Germany market information to understand reimbursement policies, regulatory requirements, and market dynamics for product registration and market authorization planning.

    Key Companies in the Germany Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise market valuations for Germany ($38.79M in 2026, $53.48M in 2031) with country-specific CAGR of 6.6%, enabling accurate financial planning and investment decisions.
    • Reimbursement & Regulatory Insights : Understand Germany's unique reimbursement landscape, insurance coverage policies, and regulatory requirements specific to gastrointestinal stents, critical for market entry and pricing strategies.
    • Competitive Landscape Analysis : Identify key players, market share distribution, and competitive positioning within Germany's gastrointestinal stent market to inform strategic partnerships and differentiation strategies.
    • Growth Driver Identification : Discover Germany-specific factors driving market growth including aging demographics, clinical adoption rates, and healthcare infrastructure advantages for targeted business development.
    • Strategic Market Entry Planning : Leverage Germany-focused data to develop market entry strategies, identify distribution channels, and establish partnerships with leading German healthcare institutions and providers.

    Frequently asked questions

    What is the current market size of gastrointestinal stents in Germany?

    Germany's gastrointestinal stent market is valued at $38.79 million in 2026 and is expected to reach $53.48 million by 2031.

    What is the projected growth rate for Germany's gastrointestinal stent market?

    Germany's gastrointestinal stent market is projected to grow at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2031.

    What factors are driving growth in Germany's gastrointestinal stent market?

    Key drivers in Germany include an aging population, rising prevalence of gastrointestinal disorders, strong healthcare infrastructure, favorable reimbursement policies, and increasing adoption of minimally invasive endoscopic procedures.

    How does Germany's healthcare system support the gastrointestinal stent market?

    Germany's advanced healthcare infrastructure, comprehensive reimbursement coverage, high hospital standards, and physician expertise in endoscopic interventions create a favorable environment for gastrointestinal stent adoption.

    What types of gastrointestinal stents are used in Germany?

    Germany utilizes various stent types including biliary stents, esophageal stents, colorectal stents, and duodenal stents, with selection based on clinical indication and patient-specific factors.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status